SCHEMBL5504175

SCHEMBL5504175

O=c1c2oc3c(OC(F)F)cccc3c2cnn1C1CCCC1

nearest known ligand 0.37

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ PDE9A O76083 18/20 0.37
▸ TNF P01375 2/20 0.34
▸ LITAF Q99732 2/20 0.34
▸ PDE1C Q14123 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL72926 0.80 PDE4D (0.37) PDE9APDE1C
SCHEMBL3873741 0.76 PDE4B (0.36) —
SCHEMBL84902 0.73 PDE4D (0.54) —
SCHEMBL3872957 0.71 MAPT (0.35) PDE9A
SCHEMBL29703260 0.63 GAA (0.47) PDE9APDE1C
SCHEMBL5501126 0.61 ADORA2A (0.39) —
SCHEMBL30881895 0.60 SMN1; SMN2 (0.47) —
SCHEMBL28282726 0.57 ADRA1A (0.39) —
SCHEMBL10670636 0.56 BRD4 (0.45) PDE9A
SCHEMBL9828687 0.56 CNR2 (0.60) PDE9APDE1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831227-A2 NOVEL HETEROCYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS Glenmark Pharmaceuticals S.A. (CH) 2007-09-12 — — EP claimed
WO-2006064355-A2 NOVEL HETEROCYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS GLENMARK PHARMACEUTICALS S.A. (US) 2006-06-22 — — WO claimed
Send feedback